logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Healthcare Services
Filter

Healthcare Services

Categories

Sectors

Locations

Exchange

10 China battery leaders riding Yahua’s Zimbabwe move

Feb 27, 2026

Patience Pays Off: Why These Two Healthcare Giants Are Worth the Wait

Patience Pays Off: Why These Two Healthcare Giants Are Worth the Wait

Feb 26, 2026

Life Science

Parabilis Shatters Biotech IPO Record, Stock Surges 58% in Nasdaq Debut

What Will Drive Regeneron Pharmaceuticals in the Next Decade?

Feb 24, 2026

Life Science

如何规划五万美元投资?三大科技领军企业的长期价值分析

Aiming at a Billion-Dollar Market, Pfizer Doubles Down on Obesity Therapies in China

Feb 24, 2026

Life Science

重金布局能源,谷歌47.5亿美元收购Intersect

This Weight-Loss Drug ‘Dark Horse’ Could Take You for a Ride

Feb 23, 2026

Life Science

Goeasy Shares Crater 57% After Suspending Dividend, Flagging Bad Loan Charges

Novo Nordisk Shares Plunge 16% as CagriSema Lags Behind Lilly’s Drug in Key Trial

Feb 23, 2026

Life Science

英特尔押注AI未来,传计划收购SambaNova

Will One Comment from Eli Lilly Turn Around Novo Nordisk’s Stock?

Feb 20, 2026

Life Science

硅谷权力更迭,Alphabet凭AI强势回归

Searching for the Next ‘Star Stock’? Wall Street Recommends These Two Biotech Stocks

Feb 19, 2026

Life Science

Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock

Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock

Feb 19, 2026

Life Science

ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva

ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva

Feb 18, 2026

Life Science

AI热潮冷却?博通业绩亮眼却难挽股价颓势

AI Empowers New Drug Development at the Right Time: These Two Biotech Stocks Are Not to Be Missed

Feb 12, 2026

Life Science

药物获批与收购潜力形成“双击”,Travere Therapeutics股价获强劲助推

Four ETFs May Usher in Explosive Growth

Feb 11, 2026

Life Science

特朗普药品关税政策对礼来公司的影响分析

Revenue Highly Dependent on the GLP-1 Track: How Does Lilly Balance Growth and Risk?

Feb 9, 2026

Life Science

Hims & Hers Stock Plunges 25% After Abandoning Copycat Wegovy Pill

Hims & Hers Stock Plunges 25% After Abandoning Copycat Wegovy Pill

Feb 9, 2026

Life Science

挑战还是机遇?联合健康集团迎来价值重塑的关键时刻

Biogen’s Financial Report and Outlook Exceed Expectations, Stock Soars Nearly 9% on Friday 

Feb 6, 2026

Life Science

联合健康深陷困境,股价暴跌59%后是机遇?

Amazon Begins Selling Oral Weight-Loss Drug Wegovy, Intensifying Competition in the GLP-1 Retail Market

Feb 5, 2026

Life Science

AI驱动未来医疗,BioNTech股价应声上涨近4%

Weight Loss Drug Giant Eli Lilly’s Market Cap Surges Nearly $100 Billion, Accelerating Expansion into New Gene Therapy Sector 

Feb 4, 2026

Life Science

MSCI shock jolts Jakarta, regulators promise fixes

Feb 4, 2026

Life Science

  • ‹‹ Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada